Portfolio holdings

Important Information

We want to make investing with us simple and straightforward for all of our clients.

Please select your investor type from the options below.

Alternatively you can register or log in to an existing account.

Please note that by making your selection here you are agreeing to the Woodford Investment Management Ltd Privacy Statement and to our Terms and Conditions.

Woodford Patient Capital Trust plc

Home > Funds > Woodford Patient Capital Trust plc > Portfolio Holdings

We recognise that openness and transparency are key in building client understanding and we ensure that our clients get unprecedented levels of clear and relevant information about their investments, including unparalleled access to our Investment team and transparency into our portfolio construction.

To keep our investors informed, we are committed to providing full disclosure of the Woodford Patient Capital Trust’s holdings on a monthly basis.

Please find the portfolio holdings as at 31 October 2017 below.

The details set out are for information purposes only. Care is taken in ensuring this is accurate as at the stated date. However, this is not guaranteed and the portfolio may change at any time. This does not constitute investment advice or any recommendation with regard to the listed stocks.

Register now to receive Portfolio disclosure alerts by email.

Woodford Patient Capital Trust plc As at 31 October 2017
  Name Industry % (weight)
1 Prothena Health Care 15.63
2 Oxford Nanopore (unquoted) Health Care 8.94
3 Purplebricks Financials 8.01
4 Immunocore A (unquoted) Health Care 7.23
5 Benevolent AI (unquoted) Technology 6.04
6 Autolus (unquoted) Health Care 5.53
7 Mereo Biopharma Health Care 4.50
8 Proton Partners International (unquoted) Health Care 4.27
9 Theravance Biopharma Health Care 3.84
10 Oxford Sciences Innovation (unquoted) Financials 3.41
11 Atom Bank (unquoted) Financials 2.92
12 Gigaclear (unquoted) Telecommunications 2.79
13 Kymab B Pref  (unquoted) Health Care 2.57
14 Ultrahaptics Pref (unquoted) Technology 1.92
15 Ombu (unquoted) Financials 1.90
16 Arix Bioscience  Financials 1.80
17 Malin Financials 1.79
18 Idex Technology 1.62
19 4D Pharma Health Care 1.50
20 A J Bell (unquoted) Financials 1.47
21 Inivata (unquoted) Health Care 1.24
22 Allied Minds Financials 1.17
23 Touchstone Innovations Financials 1.16
24 Cell Medica (unquoted) Health Care 1.09
25 SciFluor Life Sciences (unquoted) Health Care 1.05
26 ReNeuron Health Care 1.04
27 Xeros Industrials 1.01
28 Silence Therapeutics Health Care 0.98
29 Evofem D (unquoted) Health Care 0.98
30 Thin Film Electronics Industrials 0.96
31 Cequr (unquoted) Health Care 0.95
32 Precision Biopsy (unquoted) Health Care 0.93
33 AMO Pharma (unquoted) Health Care 0.93
34 Industrial Heat (unquoted) Industrials 0.88
35 Drayson Technologies (unquoted) Technology 0.86
36 Seedrs (unquoted) Financials 0.84
37 Mission Therapeutics (unquoted) Health Care 0.77
38 Netscientific Health Care 0.76
39 Nexeon (unquoted) Industrials 0.66
40 Vernalis Health Care 0.64
41 Mercia Technologies Financials 0.58
42 Benchmark Health Care 0.57
43 Metalysis (unquoted) Industrials 0.56
44 Kind Consumer C (unquoted) Consumer Goods 0.56
45 Mafic (unquoted) Industrials 0.56
46 Industrial Heat A2 Pref (unquoted) Industrials 0.51
47 Federated Wireless (unquoted) Technology 0.51
48 Ratesetter (unquoted) Financials 0.49
49 Accelerated Digital Ventures A (unquoted) Financials 0.42
50 Fibre 7 (unquoted) Industrials 0.41
51 Dementia Discovery Fund (unquoted) Health Care 0.40
52 Ultrahaptics (unquoted) Technology 0.38
53 PsiOxus (unquoted) Health Care 0.38
54 Sphere Medical Pref Health Care 0.37
55 Seedrs Pref (unquoted) Financials 0.34
56 Federated Wireless Pref B (unquoted) Technology 0.33
57 Novabiotics (unquoted) Health Care 0.31
58 Tissue Regenix Health Care 0.30
59 RM2 International 9% convertible Industrials 0.30
60 Itaconix Basic Materials 0.29
61 Mafic B (unquoted) Industrials 0.26
62 Kind Consumer (unquoted) Consumer Goods 0.26
63 Cambridge Innovation Capital (unquoted) Financials 0.25
64 Yoyo Wallet (unquoted) Technology 0.23
65 Oxford Pharmascience Health Care 0.22
66 Econic (unquoted) Industrials 0.20
67 American Financial Exchange (unquoted) Financials 0.19
68 Drayson Technologies C (unquoted) Technology 0.15
69 RM2 International Industrials 0.14
70 Origin (unquoted) Health Care 0.10
71 Evofem C (unquoted) Health Care 0.09
72 Northwest Biotherapeutics Health Care 0.09
73 Halosource Reg S Industrials 0.06
74 Origin (convertible pref) (unquoted) Health Care 0.06
75 Kind Consumer B (unquoted) Consumer Goods 0.04
76 Industrial Heat A3 (unquoted) Industrials 0.04
77 Ombu Pref (unquoted) Financials 0.01
78 Midatech Pharma Health Care 0.01
79 Origin (warrants) (unquoted) Health Care 0.01
80 Sphere Medical Health Care 0.01

What are the risks?

  • The value of the fund and any income from it may go down as well as up, so you may get back less than you invested
  • Past performance cannot be relied upon as a guide to future performance
  • The annual management charge is charged to capital, so the income of the fund may be higher but capital growth may be restricted or capital may be eroded
  • The fund may invest in other transferable securities, money market instruments, warrants, collective investment schemes and deposits
  • The fund may invest in overseas securities and be exposed to currencies other than pound sterling
  • The fund may invest in unquoted securities, which may be less liquid and more difficult to realise than publicly traded securities

Important information

Before investing, you should read the Key Investor Information Document (KIID) for the fund, and the Prospectus which, along with our terms and conditions, can be obtained from the downloads page or from our registered office. If you have a financial adviser, you should seek their advice before investing. Woodford Investment Management Ltd is not authorised to provide investment advice.

Woodford Investment Management Ltd is authorised and regulated by the Financial Conduct Authority (firm reference number 745433). Incorporated in England and Wales, company number 10118169. Registered address 9400 Garsington Road, Oxford OX4 2HN.

Woodford Patient Capital Trust plc is incorporated in England and Wales, company number 09405653. Registered as an investment company under section 833 of the Companies Act 2006. Registered address Beaufort House, 51 New North Road, Exeter, EX4 4EP.

The Woodford Funds (Ireland) ICAV (the “Fund”) has appointed as Swiss Representative Oligo Swiss Fund Services SA, Av. Villamont 17, 1005 Lausanne, Switzerland, Tel: +41 21 311 17 77, email: info@oligofunds.ch. The Fund’s Swiss paying agent is Neue Helvetische Bank AG. All fund documentation including, Prospectus, Key Investor Information Documents, Instrument of Incorporation and financial reports may be obtained free of charge from the Swiss Representative in Lausanne. The place of performance and jurisdiction for all shares distributed in or from Switzerland is at the registered office of the Swiss Representative. Fund prices can be found at www.fundinfo.com.

© 2017 Woodford Investment Management Ltd.
All rights reserved.

By using this website you are automatically agreeing to the Woodford Investment Management Ltd privacy statement